Page 22 - Les Meilleurs doctors pour votre CT (tomodensitométrie) - TOP 570 des médecins

Domaines d'intérêt

• Chirurgie reconstructive urogénitale pédiatrique
• Hypospadias
• Circumcision
• Chirurgie oncologique
• Anomalies congénitales du système urinaire supérieur et inférieur
• Chirurgie du nouveau-né
• Chirurgie abdominale pédiatrique

Formation
 

• 1997 - Université 19 Mayıs
• 1998 - Congrès national de chirurgie pédiatrique, Meilleure étude de recherche
• 2001 - Université Kocaeli
• 2007 - Gouvernement du Kosovo
• 2009 - Université Yeditepe
• 2009 - Congrès d'Arabie Saoudite, Meilleure étude clinique

Expérience
 

• Lycée FMV Işık
• Faculté de médecine de l’Université d’Istanbul Cerrahpaşa
• Université Ondokuz Mayıs
• Hôpital pour enfants Zeynep Kamil
• Faculté de médecine de l’Université Kocaeli
• UT Southwestern Medical Center, urologie pédiatrique, Dallas, USA
• Centre médical de l’Université Ege, urologie pédiatrique
• Université Yeditepe

Le Prof. Dr. Selami Sozubir est l’auteur de 65 publications scientifiques, ayant reçu plus de 11 000 lectures et près de 1 000 citations, ce qui témoigne de sa contribution importante dans le domaine de la chirurgie et de l’urologie pédiatriques.

Areas of Interests

• General Neurology
• Clinical Neurophysiological examinations (Electromyography, evoked potentials, electroencephalography, polysomnography)
• Peripheral Nervous System Diseases
• Muscle diseases
• Epilepsy
• Headache
• Sleep and sleep disorders
• Migraine botox and botulinum A toxin applications

Education:

• 1980-1985 Atatürk Elementary School
• 1985-1988 Anamur High School
• 1988-1991 Anamur High School
• 1991-1998 Marmara University Faculty of Medicine in English
• 2000- 2004 PTT Education and Research Hospital Neurology Clinic (Medical Specialization Student)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2012- Clinical Neurophysiology Sub-branch Specialist

Experiences:

• September 2023-Currently Haliç University Faculty of Medicine, Faculty Member
• January 2023-Currently Hisar Intercontinental Hospital, Department of Neurology
• 2014- August 2023 Bilgi University Health Sciences Vocational School Electroneurophysiology Department, Faculty Member
• 2019- 2022 Ataşehir Private Avicenna Hospital, Neurology Department
• 2009-2018 Fatih Sultan Mehmet Education and Research Hospital Neurophysiology Laboratory (Specialist Doctor)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2005-2006 Istanbul University Istanbul Faculty of Medicine Department of Neurology Electrodiagnostics Department EMG Laboratory
• 2000-2004 PTT Education and Research Hospital Neurology Clinic (Specialist Student in Medicine)

Dr. Levent Dalar is a respected pulmonologist with over 20 years of experience. He specializes in interventional bronchoscopy and rare lung diseases. Dr. Dalar has trained and worked in France, Switzerland, and Turkey. He gained valuable experience at the University of Zürich’s Lung Transplant Unit. His background gives him a broad view of advanced lung care.

Dr. Dalar is known for his work in bronchoscopic techniques. He has diagnosed and treated thousands of complex respiratory cases. His main focus is on interstitial lung diseases and respiratory deficiencies. As a professor, he helps train future specialists at top universities. He is also an active member of ERS, EABIP, SPLF, and GELF, staying involved in the latest developments in respiratory medicine.

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-

Prof. Dr. Deniz Süha Küçükaksu is a cardiovascular surgeon with over 35 years of experience. He specializes in adult and pediatric cardiac surgery, heart transplantation, and mechanical circulatory support. He leads the Heart Transplantation and Artificial Heart Center at Başkent University Istanbul Hospital.

Dr. Küçükaksu completed his medical and surgical training in Turkey. He also received advanced fellowships in Germany, France, and the United States. His focus has been on LVAD systems and heart failure surgery.

He introduced mechanical circulatory support and artificial heart programs in Turkey. He has performed many types of surgeries, including coronary bypass (off-pump), valve replacements, aortic repair (EVAR/TEVAR), and reoperations. He has also established heart transplant centers at several institutions.

Dr. Küçükaksu has held senior academic and administrative roles. He has contributed to total artificial heart surgery and hybrid cardiovascular procedures. He has received national and international awards for his scientific and surgical work.

Areas of Interests

• General Gastrointestinal Diseases
• Endoscopic procedures (gastroscopy, colonoscopy, enteroscopy, capsule endoscopy)
• Interventional endoscopy
• ERCP
• Endoscopic ultrasonography (EUS)
• Cholangioscopy
• Diseases of the biliary system and pancreas

Education:
 

• 1990 -1996 Ankara University Faculty of Medicine
• 1997 - 2001 Ankara Numune Training and Research Hospital Internal Medicine Residency
• 2001 - 2003 Turkey High Specialization Training and Research Hospital, Gastroenterology Subspecialization
• 2010 - 2010 State University of New York, USA, Department of Gastroenterology, EUS training program
   

Experience:
 

• June 2024 LIV Hospital Ulus Hospital
• 2018 - 2024 Florence Nightingale Hospitals, Gastroenterology Clinic
• 2013 - 2018 Memorial Ataşehir Hospital, Gastroenterology Clinic
• 2008 - 2013 Gaziantep University Faculty of Medicine, Department of Gastroenterology, Assoc. Prof. Dr.
• 2008 - 2008 Medicalpark Gaziantep Hospital Gastroenterology Clinic
• 2004 - 2008 Gaziantep State Hospital Gastroenterology Clinic, Endoscopy Unit Founding Physician

Publications

• Arhan M, Koklu S, Koksal AS, Yolcu OF, Koruk S, Koruk I, Kayacetin E. Alverine citrate induced acute hepatitis. World J Gastroenterol 2004; 10(15): 2303-4  ISSN: 1007-9327
• Parlak E, Cicek B, Koruk I, Disibeyaz S, Sahin B. Successful prevention of stent migration caused by placement of a second stent. Endoscopy. 2005; 37(4): 404. ISSN: 0013-726X
• Koruk I, Ozturk ZA, Köklü S, Koruk S, Ozdede S. Port-site metastasis after laparoscopic cholecystectomy. Acta Gastroenterol Belg. 2008; 71(2): 283-4      ISSN:0001-5644
• Koruk I, Parlak E, Secilmis S, Akdogan M, Koklu S.  Endoscopic sphincteroplasty with large balloon dilatation for extraction of difficult common bile duct stones. Dig Dis Sci. 2008 Jun;53(6):1737-8. ISSN: 0163-2116
• Ozkaya M, Yuzbasioglu MF, Koruk I, Cakal E, Sahin M, Cakal B. Preoperative detection of insulinomas: two case reports. Cases J. 2008 Nov 29; 1(1): 362  ISSN: 1757-1626
• Yılmaz Ö, Koruk İ, Çayır K, Koruk M, Yılmaz A. Usefullness of serum insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) for colorectal cancer diagnosis. Int J Hematol Oncol 2009; 19(1): 23-27  ISSN: 1306-133X
• Savaş C, Koruk İ, Koruk M, Kadayıfçı A, Sarı İ. Association of prion protein with the stage of liver fibrosis in chronic viral hepatitis. Trakya Univ Tip Fak Derg. 2010; 27(4): 373-7. DOI: 10.5174/tutfd.2009.02284.1 ISSN: 1301-3149
• Buyukberber M, Koruk I, Cıkman O, Koruk M, Kucukoglu ME, Sakman A, Demir O, Sahinoz S. Serum cystatin C measurement in differential diagnosis of intra and extrahepatic cholestatic diseases. Ann Hepatol 2010; 9(1): 58-62  ISSN: 1665-2681
• Gulsen MT, Koruk I, Dogan M, Beyazit Y. Diagnostic accuracy of cascade stomach by upper gastrointestinal endoscopy in patients with obscure symptoms: A multi-center prospective trial. Clin Res Hepatol Gastroenterol. 2011; 35: 489-93. DOI: 10.1016/j.clinre.2011.03.004         ISSN: 2210-7401
• Koruk I, Aydın U, Koruk S, Aydınlı M. A newly defined biliary anatomic variation. Turk J Gastroenterol 2011; April 22(2): 232-3  DOI:10.4318/ tjg.2011.0204  ISSN: 1300-4948
• Koruk İ, Özdemir H, Aydınlı M, Tarakçıoğlu M, Koruk M. The relation between serum Cytokeratin 18 and acute pancreatitis: Can it be a serological predictive marker?. Turk J Gastroenterol. 2011. DOI:10.4318/tjg.2011.0256 ISSN: 1300-4948
• Aydinli M, Koruk I, Koruk S, Aydin U, Kadayifci A. Intraoperative cholangioscopy with an ultrathin endoscope for hemobilia. Endoscopy 2011;43 Suppl 2 UCTN:E410. doi: 10.1055/s-0030-1256897. Epub 2012 Jan 24
• Aydinli M, Koruk I, Dag MS, Savas MC, Kadayifci A. Ultrathin endoscopy for gastrointestinal strictures. Digestive Endoscopy 2012 May;24(3):150-3. doi: 10.1111/j.1443-1661.2011.01206.x. Epub 2011 Oct 27                 ISSN: 0915-5635
• Yılmaz Ö, Koruk İ, Onbaş O, Ozgokce M. Portal venous gas resulting from enteritis in a case with portal hypertension: Case report. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2012; 32 (4): 1195-8 ISSN: 1300-0292
• Demiryürek S, Koruk I, Bozdag Z, Ozkara E, Kaplan DS, Oztuzcu S, Cetinkaya A, Alasehirli B, Demiryürek AT. Investigation of the esophageal Rho-kinase expression in patients with Barrett's esophagus. Ultrastruct Pathol. 2013 Aug;37(4):284-9. doi: 10.3109/01913123.2013.797064        ISSN: 0191-3123
• Dag MS, Ozturk ZA, Koruk I, Kısacık B, Gerenli O, Aydınlı M, Kadayıfcı A. Intestinal Behcet's disease with severe pulmonary arterial involvement mimicking ulcerative colitis. Asian Biomedicine. 2013; 7(5): 715-8      ISSN: 1905-7415
• Dağ MS, Aydınlı M, Oztürk ZA, Türkbeyler IH, Koruk I, Savaş MC, Koruk M, Kadayıfçı A. Drug- and herb-induced liver injury: a case series from a single center. Turk J Gastroenterol. 2014 Feb;25(1):41-5. doi: 10.5152/tjg.2014.4486ISSN: 1300-4948
• Kadayifci A, Atar M, Parlar S, Balkan A, Koruk I, Koruk M. Transnasal endoscopy is preferred by transoral endoscopy experienced patients. J Gastrointestin Liver Dis. 2014 Mar;23(1):27-31     ISSN: 1841-8724
• Alasehirli B, Oğuz E, Oksuzler E, Koruk I, Oztuzcu S, Ozkara E, Karakok M, Erbagcı AB, Demiryurek AT. Investigation of intercellular adhesion molecules (ICAMs) gene expressions in patients with Barrett's esophagus. Tumour Biol. 2014 May;35(5):4907-12. doi: 10.1007/s13277-014-1644-3      ISSN: 1010-4283
• Dag M, Özturk Z, Aydınlı M, Koruk I, Kadayfçı A. Postpartum hepatotoxicity due to herbal medicine Teucrium polium. Ann Saudi Med. 2014 Nov-Dec;34(6):541-3. doi: 10.5144/0256-4947.2014.541        ISSN: 0256-4947
• Tahtacı M, İbiş M, Koruk İ, Parlak E. Endoscopic removal of fractured basket traction wire. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:324-5. doi: 10.5152/tjg.2014.6582            ISSN: 1300-4948
• Dağ MS, Koruk İ, Aydınlı M, Çam H, Öztürk ZA, Kadayıfçı A. An unusual cause of esophageal ulcer; sertraline hydrochloride. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:250-1. doi: 10.5152/tjg.2014.4646  ISSN: 1300-4948
• Balkan A, Yılmaz N, Balkan Y, Koruk İ, Örkmez M, Aydınlı M, Koruk M. Relationship between liver injury and serum cytokeratin 18 levels in asymptomatic hepatitis B virus carriers and in patients with chronic hepatitis B infection. Arab Journal of Gastroenterology. 2017; 18: 98–103                   ISSN: 1687-1979
• Koruk İ. How to manage difficult cannulation in ERCP. Gastroenterology and Hepatology: Open Access. 2017, 6(3): 00194. DOI: 10.15406/ghoa.2017.06.00194 ISSN: 2373-6372
• Valori R, Cortas G, de Lange T, Balfaqih OS, de Pater M, Eisendrath P, Falt P, Koruk I, et al.  Performance measures for endoscopy services: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative.  Endoscopy 2018; 50: 1186–1204   ISSN 0013-726X
• Koruk S, Koruk I, Mizrak A. A, Bilgi M, Gul R, Bozgeyik S. Dexmedetomidine or midazolam in combination with propofol for sedation in endoscopic retrograde cholangiopancreatography: a randomized double blind prospective study. Videosurgery Miniinv. 2020; 15(3): 526-32 doi.org/10.5114/wiitm.2020.95066

Areas of Interests

• Pituitary Diseases
• Thyroid Diseases
• Obesity
• Diabetes
• Female and Male Reproductive System Diseases
• Parathyroid Diseases
• Adrenal Gland Diseases
• Osteoporosis and Metabolic Bone Diseases

Education:

• Hacettepe University Faculty of Medicine
• Bezmialem Foundation University
• Health Sciences University Bakirkoy Dr. Sadi Konuk Training and Research Hospital
• Cleveland Clinic, The Endocrinology and Metabolism Institute observer physician
• University of Piemonte Orientale, SCDU Endocrinology, Italy, observer physician
   

Experience:
 

• Mehmet Akif Inan Training and Research Hospital
• Bakirkoy Dr. Sadi Konuk Training and Research Hospital
• Bezmialem Vakif University Hospital
• Malatya State Hospital

Dr. Cagri Canbolat is a neurosurgeon. He specializes in neuro-oncological surgery, skull base surgery, neurovascular surgery, minimally invasive spinal surgery, oncological spinal surgery, pediatric neurosurgery, neuro-trauma, and neuro-intensive care. He completed his medical education and neurosurgery training at Cumhuriyet University Faculty of Medicine from 2005 to 2018.

Dr. Canbolat has contributed to research on the therapeutic effects of Etanercept and Ustekinumab in spinal cord injury models. He has also studied the genetics of neural tube defects. His publications include work on primary central nervous system lymphoma and surgical outcomes in elderly patients with intracranial meningioma. He has analyzed 228 cases in these studies.

He has worked at Liv Hospital Vadistanbul, Memorial Service Hospital, Acıbadem Maslak Hospital, and Vezirköprü State Hospital.

Dr. Gokhan Kursat Kara is an orthopaedic surgeon with expertise in spine surgery, arthroplasty, and trauma and deformity correction. He graduated from Istanbul University Medical Faculty. He completed his residency in orthopaedics and traumatology at Uludag University.

Dr. Kara has worked at several top hospitals. He has been with Liv Hospital since 2016. He has published many articles in peer-reviewed journals. His research covers tendon repair, developmental dysplasia of the hip, spinal arthropathy, and surgical methods for scoliosis and vertebral fractures.

Dr. Erkancakir is a specialist in pediatric chest diseases. He has experience with acute and chronic respiratory problems, respiratory tract infections, and bronchoscopic procedures. His areas of focus include asthma, sleep-related breathing disorders, cystic fibrosis, and tuberculosis.

He completed his medical degree at Istanbul University. He continued his specialty training at Göztepe Training and Research Hospital and Marmara University. Dr. Erkancakir has worked at leading institutions, such as Bezmialem Vakıf University and Süreyyapaşa Chest Diseases Training and Research Hospital.

He is an active member of several professional organizations, including the Turkish Thoracic Society and the European Respiratory Society. Dr. Erkancakir has received more than 20 national and international awards for his research and presentations, especially in pediatric pulmonology and cystic fibrosis.

Dr. Binnur Simsek is a gastroenterology specialist. She has experience in liver cirrhosis, portal hypertension, hepatocellular carcinoma, liver transplantation, and viral hepatitis (B, C, Delta). She also treats alcoholic and non-alcoholic fatty liver disease, peptic ulcers, gastrointestinal bleeding, and inflammatory bowel diseases such as ulcerative colitis and Crohn’s colitis.

She completed her medical and gastroenterology training at Istanbul University Faculty of Medicine. Dr. Simsek has worked at Istanbul University, Sanlıurfa Education and Research Hospital, Liv Hospital, and Istinye University. She is a member of the Turkish Association for the Study of the Liver and the Turkish Society of Gastroenterology.

Areas of Interests

• MR Linac
• Three Dimensional Brachytherapy
• Four Dimensional (4D) Radiotherapy
• Stereotactic RT & IMRT
• Breast Cancer, Gynecological Cancers
• Head – Neck Cancers
• Urological Tumors, Gastrointestinal Cancers
• Lung Cancer
• Central Nervous System Tumors & Metastases
• Skin Cancers
• Soft Tissue Tumors

Education:

• Istinye University Medical Faculty, Professor Doctor (2017 – Continued)
• Istine University Medical Faculty Associate Professor Doctor (2016 – 2017)
• Liv Hospital Radiation Medicine Center, Tbilisi, Georgia, Radiation Oncology Consulting Docor (2016 – 2019)
• Liv Hospital, Radiation Oncology (2015 – Continued)
• Istanbul University Oncology Institution, Associate Professor (2012 – 2015)
• Stereotactic Radiotherapy, Thoracic Oncology, University of North Carolina, NC, USA (2010 – 2011)
• Kocaeli University Radiation Oncology Department, Associate Professor Assistant (2006 – 2009)
• GATA Radiation Oncology Department, Specialist Doctor, Reserve Officer (2004 – 2005)
• Istanbul University, Medical Faculty, Dr.R.A. (1999 – 2004)
• Istanbul University, Medical Faculty, Under-Graduate (1993 – 1999)
   

Experience:

• Istinye University Medical Faculty
• Liv Hospital Ulus
• Istanbul University Oncology Institution
• University of North Carolina, NC, USA
• Kocaeli University Medical Faculty
• Istanbul University, Medical Faculty

Areas of Interests

• Parkinson's disease
• Essential tremor
• Dystonia and other involuntary movements
• Balance and gait disorders
• Alzheimer's Disease and other dementias
• Spasticity
• Brain vascular diseases
• Migraine and other headaches
• Epilepsy
• Botulinum toxin application in dystonia
• Botulinum toxin application in spasticity
• Botulinum toxin application in migraine headache

Education:

• Bachelor of Medicine Ankara University 1988-1994
• Medical Specialization Neurology Ankara University Faculty of Medicine 1995-2000
• Associate Professorship Neurology Cumhuriyet University Faculty of Medicine 09/10/ 2013

Experience:

• General Practitioner Ankara Yenimahalle Health Center 1994-1995
• Research Assistant Ankara University Faculty of Medicine, Department of Neurology 1995-2000
• Specialist Dr. Sevgi Milennium Hospital 2000-2001
• Specialist Dr. Deda Brain Spinal Cord Diseases Center 2001-2002
• Specialist Dr. Pamukkale University Faculty of Medicine 2002-2003
• Specialist Dr Sivas Numune Hospital 2003-2007
• Specialist Dr. Private Sivas Anadolu Hospital 2007-2009
• Asst. Assoc. Dr. Department of Neurology, Cumhuriyet University Faculty of Medicine, Sivas 2009-2013
• Assoc Prof Dr Neurology Department AD, Cumhuriyet University Faculty of Medicine, Sivas October 2013- October 2016
• Assoc Prof Dr Medicana Sivas Hospital- March 2017-June 2020
• Assoc Prof Dr Medicana International Ankara Hospital August 2020-